Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

4.830

-0.020 (-0.41%)

At close: Nov 13, 2026, 4:00 PM EST

4.810

-0.020 (-0.41%)

After-hours: Nov 13, 2026, 7:51 PM EST

Ironwood Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	400.3	296.15	351.41	442.74	410.6	413.75
Revenue Growth	18.09%	-15.72%	-20.63%	7.83%	-0.76%	6.22%
Cost of Revenue	94.58	95.14	111.42	104.79	44.27	70.41
Gross Profit	305.72	201.02	239.99	337.95	366.33	343.35
Selling, General & Admin	54	82.06	143.63	142.11	115.99	111.13
Operating Expenses	54	82.06	143.63	142.11	115.99	111.13
Operating Income	251.72	118.95	96.36	195.84	250.34	232.22
Interest Expense	-28.55	-32.75	-33.29	-21.38	-7.6	-31.15
Interest & Investment Income	5.36	4.08	4.47	18.97	9.5	0.73
Other Non Operating Income (Expenses)	-1.87	-	0.25	-0.23	0.18	-1.18
EBT Excluding Unusual Items	226.66	90.28	67.79	193.2	252.42	200.61
Merger & Restructuring Charges	0.29	-20.26	-2.59	-45.82	-	0.04
Pretax Income	226.95	70.03	65.2	-948.07	252.42	200.66
Income Tax Expense	77.33	46.01	64.32	83.49	77.36	-327.79
Earnings From Continuing Operations	149.63	24.02	0.88	-1,032	175.07	528.45
Net Income to Company	149.63	24.02	0.88	-1,032	175.07	528.45
Minority Interest in Earnings	-	-	-	29.32	-	-
Net Income	149.63	24.02	0.88	-1,002	175.07	528.45
Net Income to Common	149.63	24.02	0.88	-1,002	175.07	528.45
Net Income Growth	424.10%	2629.20%	-	-	-66.87%	397.71%
Shares Outstanding (Basic)	164	162	159	155	154	162
Shares Outstanding (Diluted)	164	163	160	155	186	164
Shares Change	-5.74%	1.81%	2.99%	-16.57%	13.32%	2.34%
EPS (Basic)	0.91	0.15	0.01	-6.45	1.13	3.26
EPS (Diluted)	0.91	0.15	0.01	-6.45	0.96	3.21
EPS Growth	412.03%	2583.01%	-	-	-69.98%	386.36%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	205.37	127.01	103.41	183.15	273.63	261.63
Free Cash Flow Per Share	1.25	0.78	0.65	1.18	1.47	1.59
Gross Margin	76.37%	67.88%	68.29%	76.33%	89.22%	82.98%
Operating Margin	62.88%	40.17%	27.42%	44.23%	60.97%	56.12%
Profit Margin	37.38%	8.11%	0.25%	-226.37%	42.64%	127.72%
Free Cash Flow Margin	51.31%	42.89%	29.43%	41.37%	66.64%	63.23%
EBITDA	253.54	120.83	98.37	197.41	251.76	233.74
EBITDA Margin	63.34%	40.80%	27.99%	44.59%	61.31%	56.49%
D&A For EBITDA	1.82	1.88	2.01	1.58	1.42	1.52
EBIT	251.72	118.95	96.36	195.84	250.34	232.22
EBIT Margin	62.88%	40.17%	27.42%	44.23%	60.97%	56.12%
Effective Tax Rate	34.07%	65.70%	98.65%	-	30.65%	-
Revenue as Reported	400.3	296.15	351.41	442.74	410.6	413.75

SEC Filings: 10-K · 10-Q